Facial and Rhinoplasty Symposium - The Aesthetic Society

The Aesthetic Society requires all faculty, authors, planners, reviewers, moderators, staff and all other individuals in a position to control or influence the content of an activity to disclose all financial relationships in the past 24 months. The Aesthetic Society also requires faculty/authors to disclose when off-label/ unapproved uses of products are discussed in a CME activity or included in related materials.

All identified relevant financial relationships have been mitigated and the educational content thoroughly evaluated by The Aesthetic Society for fair, balanced, and safe, effective patient care.

Christopher Surek, DO
Cypris Medical: Consultant, Stock/Options;   Galderma Laboratories: LP: Consultant, Cost Reimbursements, Honoraria, Rees; Allergan: Consultant, Cost Reimbursements, Honoraria;  

Jason Roostaeian, MD
nothing to disclose

Richard Bensimon, MD
nothing to disclose

Francisco Bravo, MD
nothing to disclose

Louis Bucky, MD
PatientFi: Advisor, Investor: Stock/Options

Steven Cohen, MD
Recure: Advisor, Investor, Luminary, Stock/Options; Merz Aesthetics: Research Support; Apyx Medical: Consultant, Investigator, Research Support, Other Compensation; Mage: Advisor, Investor, Luminary, Royalties, Stock/Options; Millennium Medical Technologies: Advisor, Consultant, Stock/Options; Paracrine: Shareholder, Investigator

Dino Elyassnia, MD
nothing to disclose

Glenn Jelks, MD
nothing to disclose

Aaron Kosins, MD
ZO Skin Health: Consultant, Shareholder; Micrins - Consultant; QMP - Consultant; Royalties

Michael Lee, MD
Durasorb - Investor

Gabriele Miotto, MD
nothing to disclose

Oren Tepper, MD
Mirrorme3D: Investor, Stock/Options

Patrick Tonnard, MD
Tulip, Inc. - Royalties

Richard Warren, MD
nothing to disclose

Richard Zoumalan, MD
nothing to disclose